Sector: Pharmaceuticals & Biotechnology

Small Cap

Haleos Labs Share Price

HALEOSLABS

₹1,500

35.00(2.39%)

24th Aug 2026 | 3:01 PM

NSE : HALEOSLABS

Open Free Demat Account

Haleos Labs Performance

Price Movement

₹1500.00

₹1445.60

₹1512.00

↘ Today's Low↗ Today's High

1 Year Performance

₹1500.00

₹1076.10

₹1774.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹1,512.00

Low₹1,445.60

Open at₹1,465.00

Prev Close₹1,465.00

Volumes1.04 K

Avg Price₹1,486.50

Lower Circuit₹1,172.00

Upper Circuit₹1,758.00

Historical Performance

3M High₹1,759.90

3M Low₹1,312.10

1 Yr High₹1,774.00

1 Yr Low₹1,076.10

3 Yr High₹1,774.00

3 Yr Low₹472.05

5 Yr High₹1,774.00

5 Yr Low₹472.05

Summary

As of 25-08-2026 02:01, Haleos Labs Ltd. share price today is ₹0, with a change of ₹-1465.00 (-100.00%) from the previous close of ₹1465. The stock opened at ₹1465 and traded between ₹1445.6 and ₹1512, with a total traded volume of 1042 shares. The company has a market capitalization of ₹442.9 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹1774 and ₹1076.1, respectively.

Haleos Labs Ltd. valuation metrics include a P/E ratio of 28, EPS of ₹57.26, and book value of ₹2.10. Profitability indicators show ROE of 8.1% along with a dividend yield of 0.1%. Haleos Labs Ltd. has reported revenue of ₹324.23 Cr and net profit of ₹15.8 Cr.

Haleos Labs Ltd. technical indicators include Day RSI at 46.18, Day MFI at 36.56, Day ADX at 15.63. Additional indicators include Commodity Channel Index (CCI) at -43.4 and Williams %R at -68.85. Momentum indicators show Day MACD at -19.67, Day MACD Signal Line at -17.69, DayATR at 65.84. Rate of Change indicators for Haleos Labs Ltd. include ROC125 at 13.35 and ROC21 at -3.85.

Exponential moving averages include EMA5 at ₹1463.2, EMA10 at ₹1468.3, EMA12 at ₹1471.9, EMA20 at ₹1485.1, EMA26 at ₹1491.5, EMA50 at ₹1494.5, EMA100 at ₹1461.6, EMA200 at ₹1394.4. Simple moving averages include SMA5 at ₹1464.4, SMA10 at ₹1458.3, SMA20 at ₹1491, SMA30 at ₹1520.2, SMA50 at ₹1502.5, SMA100 at ₹1471.4, SMA150 at ₹1400.6, SMA200 at ₹1376.5.

Support levels for Haleos Labs are placed at First Support ₹1439.87, Second Support ₹1414.73, Third Support ₹1387.47. Resistance levels are seen at First Resistance ₹1492.27, Second Resistance ₹1519.53, Third Resistance ₹1544.67. Haleos Labs Ltd. shareholding pattern shows promoter holding at 72.11%, FII holding at 0%, DII holding at 0%, public holding at 27.58%.

Haleos Labs Fundamentals

Market Cap

Below industry Median

442.90 Cr.

PE Ratio (TTM)

Above industry Median

Dividend Yield

Low in industry

0.10

Net Profit TTM

9% decr over last year

15.80

Net Profit Growth

9% decr over last year

15.80

PEG Ratio

Negative PEG TTM

-3.30

ROE

21% decr over last year

8.10

Operating Revenue TTM

324.23

Operating Revenue Growth

3% decr over last year

Book Value

Below industry Median

2.10

MFI

MFI is mid-range

36.56

RSI

RSI is mid-range

46.18

EPS (TTM)

57.26

Debt to Equity

0.51

Face Value

Operating Profit Margin Qtr.

13.29

Operating Profit Qtr.

9.12

Net Profit Qtr.

2.65

Operating Revenue Qtr.

72.94

PB Ratio

2.10

Haleos Labs Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Total Revenue	67.83	63.38	80.72	77.84	79.04
Operating Expense	58.18	57.18	69.16	67.04	68.21
Operating Profit	9.65	6.20	11.56	10.80	10.84
Depreciation	3.01	2.66	2.69	2.68	2.63
Interest	1.81	1.34	1.46	1.51	1.73
Tax	2.04	0.94	2.08	2.07	2.32
Net Profit	3.24	2.23	5.41	4.98	5.16

Haleos Labs Technicals

Haleos Labs Ltd. EMA & SMA

₹1500.00

43.60 (2.99%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹1463.2

Day EMA10 ₹1468.3

Day EMA12 ₹1471.9

Day EMA20 ₹1485.1

Day EMA26 ₹1491.5

Day EMA50 ₹1494.5

Day EMA100 ₹1461.6

Day EMA200 ₹1394.4

Haleos Labs Support and Resistance

Resistance

First Resistance₹1492.27

Second Resistance₹1519.53

Third Resistance₹1544.67

Support

First Support₹1439.87

Second Support₹1414.73

Third Support₹1387.47

Technical Indicators

Day RSI46.18

Day MFI36.56

Day ADX15.63

Day Commodity Channel Index-43.40

William-68.85

Day MACD-19.67

Day MACD Signal Line-17.69

Day ATR65.84

Day ROC12513.35

Day ROC21-3.85

Haleos Labs Shareholding Pattern

Held By	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoter	71.4	71.4	71.4	71.8	72.1	72.1
FII	0	0	0	0	0	0
DII	0	0	0	0.3	0.3	0.3
Public	28.6	28.6	28.6	27.9	27.6	27.6

Haleos Labs Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	498	569	87.35%
Week	309	397	77.83%
1 Month	461	691	66.72%
6 Month	1.21 K	1.77 K	68.40%

Haleos Labs SWOT Analysis

Strengths11

Weakness6

Opportunity1

Threats0

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Mid-range Performer (DVM)

Relative Outperformance versus Industry over 1 Year

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Growth in Net Profit with increasing Profit Margin (QoQ)

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Top Gainers

Haleos Labs Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
24 Sep, 2025	1.5	FINAL	24 Sep, 2025	Equity Share
23 Sep, 2024	1.5	FINAL		Equity Share
22 Sep, 2023	1.5	FINAL		Equity Share
22 Sep, 2022	1.5	FINAL		Equity Share
20 Sep, 2021	1.5	FINAL		Equity Share
19 Sep, 2019	1.5	FINAL		Equity Share

Haleos Labs Stock Comparison

Financials	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Amrutanjan Health Care Ltd.	Valiant Laboratories Ltd.
Price (₹)	₹526.25	₹6.55	₹205.20	₹15.46	₹518.70	₹100.52
% Change	-2.70%	4.97%	4.81%	8.26%	-3.29%	4.99%
Revenue TTM (₹ Cr)	₹526.28	₹69.99	₹291.17	₹226.23	₹511.48	₹305.93
Net Profit TTM (₹ Cr)	₹20.77	₹-176.47	₹14.68	₹31.63	₹53.97	₹16.01
PE TTM	115.10	-0.30	51.80	2.40	28.70	32.50
1 Year Return	37.97	524	55.39	56.92	-23.59	8.81
ROCE	3.56	-56.37	-	17.36	23.87	0.77

Similar Stocks

SIGACHI

Sigachi Industries Ltd.

₹ 30.45

+1.33%

WINDLAS

Windlas Biotech Ltd.

₹ 988.00

-0.56%

VINEETLAB

Vineet Laboratories Ltd.

₹ 37.00

-2.14%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 628.00

+1.80%

ZIMLAB

Zim Laboratories Ltd.

₹ 124.16

-0.70%

MEDICO

Medico Remedies Ltd.

₹ 42.09

-1.31%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 173.00

-0.31%

LASA

Lasa Supergenerics Ltd.

₹ 7.33

+1.81%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 302.20

+0.73%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 322.00

+0.00%

ORTINGLOBE

Ortin Global Ltd.

₹ 15.26

-3.96%

BROOKS

Brooks Laboratories Ltd.

₹ 61.70

+2.83%

RPGLIFE

RPG Life Sciences Ltd.

₹ 2638.00

+0.05%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 254.55

+4.99%

ALPA

Alpa Laboratories Ltd.

₹ 61.20

-2.47%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 354.00

-0.73%

NECLIFE

Nectar Lifesciences Ltd.

₹ 10.80

+3.15%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 30.44

+9.97%

INDOCO

Indoco Remedies Ltd.

₹ 220.00

-2.78%

INDSWFTLAB

Ind-Swift Laboratories Ltd.

₹ 325.35

-1.29%

LINCOLN

Lincoln Pharmaceuticals Ltd.

₹ 612.00

-0.33%

PANACEABIO

Panacea Biotec Ltd.

₹ 406.50

-1.12%

MEDICAMEQ

Medicamen Biotech Ltd.

₹ 234.00

-4.31%

THEMISMED

Themis Medicare Ltd.

₹ 120.50

+13.53%

FAQ's on HALEOSLABS

What is the Market Capitalization of Haleos Labs Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Haleos Labs Ltd. is approximately ₹ 442.9 Cr.

What are the PE and PB ratios for Haleos Labs Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Haleos Labs Ltd. is 28, and the Price-to-Book (PB) ratio is 2.1.

What is the 52-Week High and Low for Haleos Labs Ltd.?

Over the past 52 weeks, the highest price reached by Haleos Labs Ltd. shares was ₹ 1774, and the lowest price was ₹ 1076.1.

What is the current dividend yield for Haleos Labs Ltd.?

As of 6 June 2025, the dividend yield for Haleos Labs Ltd. is 0.1%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Haleos Labs Ltd.?

Significant shareholdings in Haleos Labs Ltd. typically include entities such as:

Promoter
Public
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Haleos Labs Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Haleos Labs Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Haleos Labs Ltd.?

Haleos Labs Ltd. last declared a FINAL dividend of ₹ 1.5 per share for the financial period ending 2025. The record date was set as 2025-09-24, and the payment was/is scheduled around 2025-09-24. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy